The Leadership Team at Grünenthal Group is responsible for setting the strategic direction and vision of the company in the field of pain management and related diseases. Comprising key executives such as the CEO, CFO, and Chief Scientific and Commercial Officers, this team oversees operational efficiency, drives innovation in research and development, and ensures the successful commercialization of new therapies, ultimately aiming to enhance patient outcomes globally.